Timothy Watts has over 25 years’ experience in the pharmaceutical and biotech sectors. He qualified as a chartered accountant with Coopers & Lybrand before moving to HJ Heinz. He subsequently joined ICI in 1985, initially in the corporate headquarters before moving into the ICI Pharmaceuticals Division in 1990 (subsequently spun out of ICI into Zeneca PLC) where he held a range of positions, both financial and in general management, before being appointed Finance Director of the Zeneca Pharmaceuticals business in 1998. Following Zeneca’s merger with Astra he became Group Financial Controller of AstraZeneca PLC in 2002. In 2007 Mr Watts was appointed CFO of Archimedes Pharma, a private equity backed specialty pharma company, where he served for 4 years. In February 2012 Mr Watts was appointed CFO and board member of Oxford BioMedica PLC, a leading gene and cell therapy company. He retired from Oxford BioMedica at the end of September 2017. Mr Watts is a member of the Institute of Chartered Accountants in England & Wales and the Association of Corporate Treasurers. He also was a director of the UK’s BioIndustry Association from 2013 to 2017. Mr Watts chairs the Company’s audit committee.